Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>The high prevalence of dermatophytosis in animals is usually associated with extra expenditure on prevention, diagnosis, and long‐term treatment. Humans are usually infected from animals, also from asymptomatic carriers, through direct contact or indirectly via fungus‐bearing hair, scales, and fomites. Despite the medical importance of <i>Trichophyton verrucosum</i> infections, there are limited <i>in vitro</i> data on the fungal susceptibility to antifungal drugs, including new‐generation triazoles, imidazoles, and allyloamines. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Objectives</h3><p>The aim of the current study was to evaluate comprehensively the <i>in vitro</i> activity of 11 antifungal drugs against a large collection of <i>T. verrucosum</i> isolates obtained in Poland, Latvia, Lithuania, and Slovakia from humans and animals using a microdilution assay. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p><i>In vitro</i> susceptibility testing of 11 antifungal drugs was performed according to the Clinical and Laboratory Standards Institute (CLSI) document M38. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The MICs of clotrimazole, ciclopirox, enilconazole, miconazole, naftifine, and terbinafine against all <i>T. verrucosum</i> isolates were below 1 μg/ml, whereas those of fluconazole, griseofulvin, itraconazole, ketoconazole, and voriconazole were above 1 μg/ml. Ciclopirox was demonstrated to have superior activity against all strains in comparison with the other drugs, whereas fluconazole exerted the weakest <i>in vitro</i> effect and exhibited the highest MIC values. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Our study has shown that drugs of different chemical origin have satisfactory antifungal activity and can be promising candidates for the treatment of <i>T. verrucosum</i> dermatophytosis. Moreover, no significant disparity in drug sensitivity between isolates obtained from different hosts and geographical regions have been demonstrated. </p></section>

In vitro activities of flutrimazole against fungal pathogens isolated from tinea pedis

Comparative Evaluation of ATB FUNGUS 3 Procedure and CLSI M27-A2 Broth Microdilution Method for Antifungal Susceptibility Testing of Pathogenic Yeasts

Evaluation of efficacy and safety of flutrimazole cream 1% in the treatment of tinea pedis

Evaluation of in Vitro Antifungal Activities of Bifonazole-triamcinolone Acetonide Against Dermatophytes

In vitro activity of terbinafine in combinations with other antifungi drugs against clinical pathogenic fungi of vulvovaginal candidiasis

Evaluation of in vitro antifungal activities of six antifungal agents against dermatophytes

In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis

In Vitro Activity of Antifungal Drugs Against Trichophyton rubrum and Trichophyton mentagrophytes spp. by E-Test Method and Non-supplemented Mueller–Hinton Agar Plates

In Vitro Activities of Terbinafine against Cutaneous Isolates of Candida albicans and Other Pathogenic Yeasts

Comparison of in vitro activities of 11 antifungal agents against Trichophyton verrucosum isolates associated with a variety hosts and geographical origin

In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species

In vitro activities of nine antifungal agents against rare pathogenic fungi.

In vitro susceptibility testing of eight antifungal agents against pathogenic fungi isolated from superficial mycoses

In vitro antifungal oral drug and drug-combination activity against onychomycosis causative dermatophytes

Antifungal susceptibility test for pathogenic Fusarium spp in vitro

In vitro susceptibility testing of the combination of terbinafine and itraconazole against dematiaceous fungi

In Vitro Susceptibility Testing of 16 Strains of Exophiala Dermatitidis to 6 Commonly Used Antifungal Agents.

In vitro susceptibility testing of domestic terbinafine hydrochloride against dermatophytes

Detection of in vitro anti-fungal activity of 20 tetralin compounds

In Vitro Antifungal Susceptibility Of Griseofulvin, Fluconazole, Itraconazole And Terbinafine Against Clinical Isolates Of Trichophyton Rubrum And Trichophyton Mentagrophytes

In Vitro Susceptibility Testing of Amorolfine in Pathogenic Fungi Isolated from Dermatomycosis Patients in China